Drug recall · May 8, 2013
Cherry Cepacol Sore Throat Lozenges recall
Why: Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
- Lots / codes
16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,
- Quantity
- 27,718 cases 16 count and 7,551 cases 576 count
- Company
- Reckitt Benckiser Inc, Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- March 18, 2013 · Voluntary: Firm initiated
- Classified
- May 1, 2013
- Reported
- May 8, 2013
- Ended
- August 14, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Menthol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.